{"id":"https://openalex.org/W2017908065","doi":"https://doi.org/10.1158/1535-7163.targ-13-a165","title":"Abstract A165: Antitumor activity of mTOR kinase inhibitor CC-223 in a mouse model of prostate cancer.","display_name":"Abstract A165: Antitumor activity of mTOR kinase inhibitor CC-223 in a mouse model of prostate cancer.","alternate_titles":[],"publication_year":2013,"publication_date":"2013-11-01","ids":{"openalex":"https://openalex.org/W2017908065","doi":"https://doi.org/10.1158/1535-7163.targ-13-a165","mag":"2017908065"},"language":"en","primary_location":{"id":"doi:10.1158/1535-7163.targ-13-a165","doi":"https://doi.org/10.1158/1535-7163.targ-13-a165","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1535-7163.targ-13-a165","pdf_url":null,"source":{"id":"https://openalex.org/S48437117","display_name":"Molecular Cancer Therapeutics","issn_l":"1535-7163","issn":["1535-7163","1538-8514"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Molecular Cancer Therapeutics","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2017908065"],"child_works_count":0,"type":"conference-abstract","is_traditional":false,"indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5033160069","display_name":"Rama Krishna Narla","orcid":"https://orcid.org/0000-0001-5181-3376","observed_orcids":["https://orcid.org/0000-0001-5181-3376"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Rama Krishna Narla","raw_affiliation_strings":["Celgene Corp., San Diego, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Celgene Corp., San Diego, CA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5075792863","display_name":"Sophie X. Peng","orcid":"https://orcid.org/0009-0004-9268-8195","observed_orcids":["https://orcid.org/0009-0004-9268-8195"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Sophie Peng","raw_affiliation_strings":["Celgene Corp., San Diego, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Celgene Corp., San Diego, CA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5069678688","display_name":"Jim Gamez","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Jim Gamez","raw_affiliation_strings":["Celgene Corp., San Diego, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Celgene Corp., San Diego, CA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5052803577","display_name":"Jason D. Katz","orcid":"https://orcid.org/0009-0006-8080-9409","observed_orcids":["https://orcid.org/0009-0006-8080-9409"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Jason Katz","raw_affiliation_strings":["Celgene Corp., San Diego, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Celgene Corp., San Diego, CA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5017812973","display_name":"Julius L. Apuy","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Julius Apuy","raw_affiliation_strings":["Celgene Corp., San Diego, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Celgene Corp., San Diego, CA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5107791867","display_name":"Mehran Fallah Moghaddam","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Mehran Moghaddam","raw_affiliation_strings":["Celgene Corp., San Diego, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Celgene Corp., San Diego, CA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5023567517","display_name":"Kimberly E. Fultz","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Kimberly E. Fultz","raw_affiliation_strings":["Celgene Corp., San Diego, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Celgene Corp., San Diego, CA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111592343","display_name":"Sabita Sankar","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Sabita Sankar","raw_affiliation_strings":["Celgene Corp., San Diego, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Celgene Corp., San Diego, CA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5091699052","display_name":"Deborah S. Mortensen","orcid":"https://orcid.org/0000-0002-9144-0962","observed_orcids":["https://orcid.org/0000-0002-9144-0962"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Deborah S. Mortensen","raw_affiliation_strings":["Celgene Corp., San Diego, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Celgene Corp., San Diego, CA","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5071075483","display_name":"Heather K. Raymon","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Heather K. Raymon","raw_affiliation_strings":["Celgene Corp., San Diego, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Celgene Corp., San Diego, CA","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":2,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"12","issue":"11_Supplement","first_page":"A165","last_page":"A165"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10952","display_name":"PI3K/AKT/mTOR signaling in cancer","score":1.0,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10952","display_name":"PI3K/AKT/mTOR signaling in cancer","score":1.0,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10543","display_name":"Prostate Cancer Treatment and Research","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T12829","display_name":"Advanced Breast Cancer Therapies","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/mtor-inhibitors","display_name":"mTOR inhibitors","score":0.921999990940094},{"id":"https://openalex.org/keywords/prostate-cancer","display_name":"prostate cancer","score":0.9700000286102295},{"id":"https://openalex.org/keywords/pharmacokinetic-pharmacodynamic-relationship","display_name":"pharmacokinetic-pharmacodynamic relationship","score":0.8019999861717224},{"id":"https://openalex.org/keywords/p-akt","display_name":"pAKT","score":0.781000018119812},{"id":"https://openalex.org/keywords/tumor-growth-inhibition","display_name":"tumor growth inhibition","score":0.8949999809265137},{"id":"https://openalex.org/keywords/apoptosis","display_name":"apoptosis","score":0.8240000009536743},{"id":"https://openalex.org/keywords/cell-proliferation","display_name":"cell proliferation","score":0.8349999785423279},{"id":"https://openalex.org/keywords/tumor-angiogenesis","display_name":"tumor angiogenesis","score":0.7369999885559082},{"id":"https://openalex.org/keywords/blood-vessel-density","display_name":"blood vessel density","score":0.7599999904632568},{"id":"https://openalex.org/keywords/anticancer-activity","display_name":"anticancer activity","score":0.8199999928474426},{"id":"https://openalex.org/keywords/mouse-xenograft-model","display_name":"xenograft mouse model","score":0.6150000095367432},{"id":"https://openalex.org/keywords/rapamycin","display_name":"rapamycin","score":0.5260000228881836}],"concepts":[{"id":"https://openalex.org/C2780192828","wikidata":"https://www.wikidata.org/wiki/Q181257","display_name":"Prostate cancer","level":3,"score":0.5896766781806946},{"id":"https://openalex.org/C98490376","wikidata":"https://www.wikidata.org/wiki/Q14876060","display_name":"mTORC1","level":4,"score":0.5798261165618896},{"id":"https://openalex.org/C86554907","wikidata":"https://www.wikidata.org/wiki/Q285613","display_name":"PI3K/AKT/mTOR pathway","level":3,"score":0.5520824790000916},{"id":"https://openalex.org/C184235292","wikidata":"https://www.wikidata.org/wiki/Q421851","display_name":"Kinase","level":2,"score":0.5145910978317261},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.5120552182197571},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.4914966821670532},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.48024824261665344},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.44480639696121216},{"id":"https://openalex.org/C190283241","wikidata":"https://www.wikidata.org/wiki/Q14599311","display_name":"Apoptosis","level":2,"score":0.37562617659568787},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.3388306796550751},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.2643499970436096},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.10439169406890869}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1158/1535-7163.targ-13-a165","doi":"https://doi.org/10.1158/1535-7163.targ-13-a165","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1535-7163.targ-13-a165","pdf_url":null,"source":{"id":"https://openalex.org/S48437117","display_name":"Molecular Cancer Therapeutics","issn_l":"1535-7163","issn":["1535-7163","1538-8514"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Molecular Cancer Therapeutics","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.98580002784729,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2100639001","https://openalex.org/W1605431033","https://openalex.org/W2979770795","https://openalex.org/W2772779917","https://openalex.org/W2332762287","https://openalex.org/W2600107601","https://openalex.org/W2597907561","https://openalex.org/W2531815132","https://openalex.org/W2044638464","https://openalex.org/W2331952705"],"abstract_inverted_index":{"Abstract":[0],"CC-223":[1,23,35,69,85,104,118,152,168,193,256,282,332,396],"is":[2,15],"an":[3],"orally":[4],"active":[5],"selective":[6,26],"mammalian":[7],"target":[8],"of":[9,45,66,68,103,112,160,172,190,192,213,232,265,281,287,293,331,340,355,392,401,407],"rapamycin":[10],"(mTOR)":[11],"kinase":[12,254,394],"inhibitor":[13,255,395],"which":[14,96],"currently":[16],"in":[17,70,107,116,149,216,229,239,245,272,320,350,397],"clinical":[18],"development.":[19],"In":[20,32,78,143,248],"biochemical":[21],"assays":[22,34],"was":[24,54,105,139,197,219,243,283,333],"highly":[25],"to":[27,56,129,145,184,223,337,347],"mTOR":[28,90,253,266,393],"over":[29],"249":[30],"kinases.":[31],"cellular":[33],"inhibited":[36,258],"both":[37,288],"mTORC1":[38,289],"and":[39,48,64,94,176,207,235,270,290,295,301,304,352,414],"mTORC2":[40],"as":[41],"evidenced":[42],"by":[43,199],"inhibition":[44,89,264,286,298,339],"pS6RP(Ser":[46],"235/236)":[47],"pAkt(Ser":[49],"473).":[50],"The":[51,125,188,211],"current":[52],"study":[53],"aimed":[55],"determine":[57],"the":[58,155,170,185,230,252,277,328,338,348,408],"pharmacokinetic/pharmacodynamic":[59],"(PK/PD)":[60],"relationship,":[61],"antitumor":[62,147,279,318,329],"activity,":[63],"mechanism":[65,189],"action":[67,191],"mice":[71,108],"with":[72,81,98,109,136,251],"PC3":[73,82,110,162,195,259,321],"human":[74],"prostate":[75,260,402],"cancer":[76],"tumors.":[77,163,247,322],"PK/PD":[79],"studies":[80],"tumor-bearing":[83],"mice,":[84],"exhibited":[86,120],"a":[87,236,398],"dose-dependent":[88,121],"pathway":[91,267],"biomarkers,":[92],"pS6RP,":[93],"pAkt,":[95,302],"correlated":[97],"plasma":[99,305],"exposure.":[100],"Antitumor":[101,390],"activity":[102,148,280,330,354,391],"tested":[106],"tumors":[111,196,201,218,274],"approximately":[113],"100-150":[114],"mm3":[115],"size.":[117],"consistently":[119],"tumor":[122,132,181,261,341],"growth":[123,158,182],"inhibition.":[124],"minimum":[126],"dose":[127],"required":[128],"obtain":[130],">65%":[131],"volume":[133],"reduction":[134],"compared":[135,183,222],"vehicle":[137,186,224],"control":[138],"5":[140,175],"mg/kg":[141,166,178],"BID.":[142],"addition":[144],"showing":[146],"smaller":[150],"tumors,":[151,173],"also":[153,345],"caused":[154,169],"regression":[156,171],"or":[157],"delay":[159],"larger":[161],"At":[164],"10":[165],"BID,":[167],"whereas":[174],"1":[177],"BID":[179],"slowed":[180],"control.":[187,225],"on":[194],"characterized":[198],"analyzing":[200],"for":[202,299],"functional":[203],"markers":[204,268],"(proliferation,":[205],"apoptosis,":[206],"blood":[208,240],"vessel":[209,241],"markers).":[210],"number":[212,231],"proliferating":[214],"cells":[215,234],"CC-223-treated":[217,246,273],"significantly":[220,257],"reduced":[221],"A":[226],"significant":[227,237],"increase":[228,349],"apoptotic":[233],"decrease":[238],"density":[242],"observed":[244,278],"conclusion,":[249],"treatment":[250],"growth.":[262],"Significant":[263],"pS6RP":[269],"pAkt":[271],"suggests":[275],"that":[276,327],"mediated":[284],"through":[285,311],"mTORC2.":[291],"Maintenance":[292],">80%":[294],">60%":[296],"biomarker":[297],"pS6":[300],"respectively,":[303],"levels":[306],"greater":[307],"than":[308],"0.2":[309],"\u03bcM":[310],"8":[312],"hours":[313],"twice":[314],"daily":[315],"confers":[316],"good":[317],"efficacy":[319],"Further":[323],"immunohistochemical":[324],"data":[325],"demonstrated":[326],"not":[334],"only":[335],"due":[336,346],"cell":[342],"proliferation":[343],"but":[344],"apoptosis":[351],"antiangiogenic":[353],"CC-223.":[356],"Citation":[357,364],"Information:":[358],"Mol":[359,425],"Cancer":[360,415,426],"Ther":[361,427],"2013;12(11":[362,428],"Suppl):A165.":[363],"Format:":[365],"Rama":[366],"Krishna":[367],"Narla,":[368],"Sophie":[369],"Peng,":[370],"Jim":[371],"Gamez,":[372],"Jason":[373],"Katz,":[374],"Julius":[375],"Apuy,":[376],"Mehran":[377],"Moghaddam,":[378],"Kimberly":[379],"E.":[380],"Fultz,":[381],"Sabita":[382],"Sankar,":[383],"Deborah":[384],"S.":[385],"Mortensen,":[386],"Heather":[387],"K.":[388],"Raymon.":[389],"mouse":[399],"model":[400],"cancer.":[403],"[abstract].":[404],"In:":[405],"Proceedings":[406],"AACR-NCI-EORTC":[409],"International":[410],"Conference:":[411],"Molecular":[412],"Targets":[413],"Therapeutics;":[416],"2013":[417],"Oct":[418],"19-23;":[419],"Boston,":[420],"MA.":[421],"Philadelphia":[422],"(PA):":[423],"AACR;":[424],"Suppl):Abstract":[429],"nr":[430],"A165.":[431]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2017908065","counts_by_year":[{"year":2018,"cited_by_count":1},{"year":2016,"cited_by_count":1}],"updated_date":"2026-11-16T12:05:36.265796","created_date":"2016-06-24T00:00:00"}
